Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Jun. 28, 2014	Jun. 29, 2013
Cash flows from operating activities:
Net income	$ 38,647	$ 1,561
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	11,839	11,603
Amortization and other non-cash items	7,286	8,557
Excess tax benefit from exercises of stock options	(330)	(3)
Deferred income taxes	2,284	681
Foreign currency adjustments	(340)	(418)
Loss on assets and other, net	1,008	1,578
Income from equity investment	0	(98)
Share-based compensation expense	9,169	9,433
Changes in operating assets and liabilities:
Accounts receivable, net	(46,606)	(7,875)
Inventories	(17,304)	(5,973)
Prepaid expense and other current and non-current assets	(5,699)	(927)
Accounts payable and accrued liabilities	30,959	(4,865)
Income tax payable/recoverable	5,397	(6,103)
Other liabilities	(49)	92
Net cash provided by operating activities	36,261	7,243
Investing activities:
Purchase of property and equipment	(9,771)	(27,197)
Proceeds from sale of property and equipment	7,352	280
Purchase of securities available-for-sale	(89,060)	(26,990)
Proceeds from maturities of securities available-for-sale	62,068	58,000
Net cash (used in) provided by investing activities	(29,411)	4,093
Financing activities:
Payment of debt	(87,503)	0
Debt issuance cost	0	(116)
Excess tax benefit from exercises of stock options	330	3
Proceeds from the issuance of common stock	10,627	1,655
Tax withholding paid on behalf of employees for restricted stock units	(4,703)	(2,484)
Restricted cash associated with financing activities	45	117
Repayment of capital lease obligations	(17)	(16)
Net cash used in financing activities	(81,221)	(841)
Effect of exchange rate changes on cash	32	236
Net (decrease) increase in cash and cash equivalents	(74,339)	10,731
Cash and cash equivalents at the beginning of the period	171,898	101,662
Cash and cash equivalents at the end of the period	$ 97,559	$ 112,393